Transcription factors in myeloid development: balancing differentiation with transformation
The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Abstract
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, downregulation of PU.1 was identified as a mechanism for the induction of leukemias generated by PML-RARa, FLT3-ITD, and AML1-ETO.[43][44][45]”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [43]
In the citing paper
“PU.1, a non-canonical pioneer transcription factor that functions as a master regulator of myeloid and lymphoid lineage differentiation18–20.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [18]
In the citing paper
“Irf8 promotes GM lineage differentiation.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“In particular, Irf8 promotes monocyte differentiation as a lineage switch between monocyte and granulocyte bifurcation29.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“All activated macrophages, regardless of polarization state, express high levels of the transcription factors runt-related transcription factor 1 (RUNX1) and PU.1, which are thought to represent global regulators of macrophage phenotypic expression [20–22].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [20]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The first lymphoid progenitor population that is known to arise from MPPs is the common lymphoid progenitors (CLPs; LIN − IL-7Rα + SCA1 low KIT low”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Research works printed but not linked: 1
- Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). · DOI · Paper page
Cited by
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570
“…common myeloid progenitor; CLP, common lymphoid progenitor; MEP, megakaryocyte/erythroid progenitor; GMP, granulocyte/ macrophage progenitor. inhibition of function of other critical factors, and recruitment of alternative chromatin-modifying enzymes to target loci (Rosenbauer and Tenen, 2007).”
BackgroundTranscriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
“A genomic view of macrophage function Myeloid lineage specification and the earliest stages of myeloid differentiation require the activity of Runt-related transcription factor 1 (RUNX1”
BackgroundNeutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
“43,62,63 Runx1, expressed in a subset of microglia during early postnatal forebrain development, regulates myeloid cell proliferation and differentiation.”
BackgroundPhysiological and pathological roles for microRNAs in the immune system
O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., & Baltimore, D. (2010) · Nature Reviews Immunology · doi:10.1038/nri2708 · Cited by 1,378
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457
Self-citationMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Origin, fate and dynamics of macrophages at central nervous system interfaces
Goldmann, T., Wieghofer, P., Jordão, M. J. C., Prutek, F., Hagemeyer, N., Frenzel, K., Amann, L., Staszewski, O., Kierdorf, K., Krueger, M., et al. (2016) · Nature Immunology · doi:10.1038/ni.3423 · Cited by 1,209
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors
Paul, F., Arkin, Y., Giladi, A., Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Winter, D., Lara-Astiaso, D., Gury, M., Weiner, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.013 · Cited by 1,082
“The functions of many of these TFs are highly conserved frommouse to human, and their mutations cause severe lineage abnormalities and blood tumors (Cantor and Orkin, 2002; Rosenbauer and Tenen, 2007).”
BackgroundModulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Mitroulis, I., Ruppova, K., Wang, B., Chen, L.-S., Grzybek, M., Grinenko, T., Eugster, A., Troullinaki, M., Palladini, A., Kourtzelis, I., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.034 · Cited by 1,100
“These mediators act on HSPCs and myeloid progenitors driving myelopoiesis via inducing transcriptional networks involving transcription factors (TFs) and expression of myeloid-lineage-specific genes (Boettcher and Manz, 2017; Rosenbauer and Tenen, 2007).”
BackgroundWeng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
“, common myeloid progenitors [CMPs]), while the basic-region leucine zipper TF C/EBPa is required for the production of granulocyte/macrophage progenitors (GMPs) from CMPs (Dakic et al., 2005; Rosenbauer and Tenen, 2007).”
BackgroundInfluentialDensely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis
Novershtern, N., Subramanian, A., Lawton, L. N., Mak, R. H., Haining, W. N., McConkey, M. E., Habib, N., Yosef, N., Chang, C. Y., Shay, T., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.004 · Cited by 942
“These results support the role of chosen regulators in differentiation and are consistent with a broader paradigm in which lineage-specific promoters can dysregulate key TFs to disrupt differentiation (Rosenbauer and Tenen, 2007; Tomlins et al., 2005).”
Brown, B. N., Ratner, B. D., Goodman, S. B., Amar, S., & Badylak, S. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.034 · Cited by 926
Manz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.010 · Cited by 850
“Induction of C/EBPb by inflammatory stimuli occurs in most tissues analyzed, and expression of various C/EBP isoforms is differentially induced during macrophage and/ or granulocyte differentiation (Rosenbauer and Tenen, 2007).”
BackgroundPalantir characterizes cell fate continuities in human hematopoiesis
Setty, M., Kiseliovas, V., Levine, J., Gayoso, A., Mazutis, L., & Pe’er, D. (2018) · doi:10.1101/385328 · Cited by 836
Characterization of cell fate probabilities in single-cell data with Palantir
Setty, M., Kiseliovas, V., Levine, J., Gayoso, A., Mazutis, L., & Pe’er, D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0068-4 · Cited by 833
O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., & Baltimore, D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072108 · Cited by 681
Dissecting cell identity via network inference and in silico gene perturbation
Kamimoto, K., Stringa, B., Hoffmann, C. M., Jindal, K., Solnica-Krezel, L., & Morris, S. A. (2023) · Nature · doi:10.1038/s41586-022-05688-9 · Cited by 677
McDonald, E. R., de Weck, A., Schlabach, M. R., Billy, E., Mavrakis, K. J., Hoffman, G. R., Belur, D., Castelletti, D., Frias, E., Gampa, K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.005 · Cited by 658
“These observations are consistent with the model that myeloid leukemias suffer from a block in terminal differentiation arising as a result of aberrant TF activity (Orkin and Zon, 2008; Rosenbauer and Tenen, 2007).”
Tay, T. L., Savage, J. C., Hui, C. W., Bisht, K., & Tremblay, M. (2017) · The Journal of Physiology · doi:10.1113/jp272134 · Cited by 562
“The early development of YS microglia precursors is dependent on key transcription factors Pu.1, a member of the Ets family (Rosenbauer & Tenen, 2007) and interferon regulatory factor Irf8, which both function as heterodimers in the determination of brain macrophage phenotype (Beers et al. 2006;…”
BackgroundWishbone identifies bifurcating developmental trajectories from single-cell data
Setty, M., Tadmor, M. D., Reich-Zeliger, S., Angel, O., Salame, T. M., Kathail, P., Choi, K., Bendall, S., Friedman, N., & Pe'er, D. (2016) · Nature Biotechnology · doi:10.1038/nbt.3569 · Cited by 558
“This process can be seen as hierarchical tree with the multipotent stem and progenitor cells at the root and the mature differentiated cell types at the bottom with various precursor cells as intermediate cell types [15, 17, 30].”
BackgroundMethodRuijtenberg, S., & van den Heuvel, S. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1120925 · Cited by 553
“activity of transcription factors can promote both differentiation and cell cycle arrest and has been used in the treatment of leukemia.(137) These examples demonstrate that the tight link”
BackgroundMethodAn immune-cell signature of bacterial sepsis
Reyes, M., Filbin, M. R., Bhattacharyya, R. P., Billman, K., Eisenhaure, T., Hung, D. T., Levy, B. D., Baron, R. M., Blainey, P. C., Goldberg, M. B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0752-4 · Cited by 489
DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
Bröske, A.-M., Vockentanz, L., Kharazi, S., Huska, M. R., Mancini, E., Scheller, M., Kuhl, C., Enns, A., Prinz, M., Jaenisch, R., et al. (2009) · Nature Genetics · doi:10.1038/ng.463 · Cited by 478
“Regulation of the diverse functional repertoire of HSCs requires the coordinated action of transcription factor”
BackgroundSelf-citationRole of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
Shi, J., Whyte, W. A., Zepeda-Mendoza, C. J., Milazzo, J. P., Shen, C., Roe, J.-S., Minder, J. L., Mercan, F., Wang, E., Eckersley-Maslin, M. A., et al. (2013) · Genes & Development · doi:10.1101/gad.232710.113 · Cited by 463
Orchestrated Intron Retention Regulates Normal Granulocyte Differentiation
Wong, J. J.-L., Ritchie, W., Ebner, O. A., Selbach, M., Wong, J. W. H., Huang, Y., Gao, D., Pinello, N., Gonzalez, M., Baidya, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.052 · Cited by 462
Neutrophils in cancer: prognostic role and therapeutic strategies
Ocana, A., Nieto-Jiménez, C., Pandiella, A., & Templeton, A. J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0707-7 · Cited by 459
“instance in mice only 1–2% circulate in the peripheral blood [10].”
BackgroundHattangadi, S. M., Wong, P., Zhang, L., Flygare, J., & Lodish, H. F. (2011) · Blood · doi:10.1182/blood-2011-07-356006 · Cited by 423
Li, W., Tanikawa, T., Kryczek, I., Xia, H., Li, G., Wu, K., Wei, S., Zhao, L., Vatan, L., Wen, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.022 · Cited by 446
“, 2008), and different CEBPB isoforms can be induced during granulocyte differentiation (Marigo et al., 2010; Rosenbauer and Tenen, 2007).”
BackgroundOrigin of microglia: current concepts and past controversies
Ginhoux, F., & Prinz, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020537 · Cited by 446
Ghosh, G., Subramanian, I. V., Adhikari, N., Zhang, X., Joshi, H. P., Basi, D., Chandrashekhar, Y. S., Hall, J. L., Roy, S., Zeng, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42980 · Cited by 420
Neutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
“Early in the neutrophil differentiation process, cells develop phagocytic capacity followed by development of oxygen-dependent microbicidal activity, increased adhesiveness, cell motility, chemotactic response, and other cell type-specific traits, proceeding through a well-characterized, carefully regulated, multi-ste…”
BackgroundPanopoulos, A. D., & Watowich, S. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.002 · Cited by 394
Myeloid Lineage Commitment from the Hematopoietic Stem Cell
Iwasaki, H., & Akashi, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.004 · Cited by 394
Severe congenital neutropenias
Skokowa, J., Dale, D. C., Touw, I. P., Zeidler, C., & Welte, K. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.32 · Cited by 383
Taskesen, E., Bullinger, L., Corbacioglu, A., Sanders, M. A., Erpelinck, C. A. J., Wouters, B. J., van der Poel-van de Luytgaarde, S. C., Damm, F., Krauter, J., Ganser, A., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307280 · Cited by 384
“Median (range) 80 (0-100) 80 (0-97) 78 (2-100)”
Microglial Physiology and Pathophysiology: Insights from Genome-wide Transcriptional Profiling
Crotti, A., & Ransohoff, R. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.013 · Cited by 323
“PU.1 is a member of the ETS family of transcription factors (Rosenbauer and Tenen, 2007), and its targeted disruption leads to the lack of B cells, monocytes, macrophages, and parenchymal microglia (Beers et al., 2006; McKercher et al., 1996).”
BackgroundRoe, J.-S., Mercan, F., Rivera, K., Pappin, D. J., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.011 · Cited by 337
“…of C/EBP and ETS family members in RN2, we identified C/EBPa, C/EBPb, FLI1, PU.1, and ERG as candidates, which are all TFs known to play a role in hematopoietic stem cell self-renewal and/or myeloid cell differentiation (Kruse et al., 2009; Rosenbauer and Tenen, 2007) (Figures 1C and S1D).”
BackgroundArinobu, Y., Mizuno, S.-I., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf, T., Mayfield, R., Chan, S., Kastner, P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.004 · Cited by 309
Jan, M., Chao, M. P., Cha, A. C., Alizadeh, A. A., Gentles, A. J., Weissman, I. L., & Majeti, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100551108 · Cited by 311
“Mutations in these transcription factors that regulate myeloid differentiation (35) may directly regulate TIM3 transcription or may arrest leukemic cells in a stage of differentiation normally associated with high TIM3 expression.”
BackgroundPulikkan, J. A., Dengler, V., Peramangalam, P. S., Peer Zada, A. A., Müller-Tidow, C., Bohlander, S. K., Tenen, D. G., & Behre, G. (2010) · Blood · doi:10.1182/blood-2009-08-240101 · Cited by 285
Self-citationZuber, J., Rappaport, A. R., Luo, W., Wang, E., Chen, C., Vaseva, A. V., Shi, J., Weissmueller, S., Fellman, C., Taylor, M. J., et al. (2011) · Genes & Development · doi:10.1101/gad.17269211 · Cited by 279
“To identify genes that might mediate these effects, we focused our subsequent analysis on differentially expressed transcription factors, as these molecules govern cell fate in normal hematopoiesis (Rosenbauer and Tenen 2007).”
BackgroundPositive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation
Kueh, H. Y., Champhekar, A., Nutt, S. L., Elowitz, M. B., & Rothenberg, E. V. (2013) · Science · doi:10.1126/science.1240831 · Cited by 273
Dendritic cells in cancer immunology
Murphy, T. L., & Murphy, K. M. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00741-5 · Cited by 269
Lipid and Lipoprotein Metabolism in Microglia
Loving, B. A., & Bruce, K. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00393 · Cited by 255
Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation
Kurotaki, D., Osato, N., Nishiyama, A., Yamamoto, M., Ban, T., Sato, H., Nakabayashi, J., Umehara, M., Miyake, N., Matsumoto, N., et al. (2013) · Blood · doi:10.1182/blood-2012-06-437863 · Cited by 252
Ng, S. Y.-M., Yoshida, T., Zhang, J., & Georgopoulos, K. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.014 · Cited by 247
“Lineage restrictions in hematopoiesis have been extensively investigated using both cellular and genetic approaches (Busslinger, 2004; Cantor and Orkin, 2002; Rosenbauer and Tenen, 2007; Rothenberg, 2007).”
WTAP is a novel oncogenic protein in acute myeloid leukemia
Bansal, H., Yihua, Q., Iyer, S. P., Ganapathy, S., Proia, D., Penalva, L. O., Uren, P. J., Suresh, U., Carew, J. S., Karnad, A. B., et al. (2014) · Leukemia · doi:10.1038/leu.2014.16 · Cited by 243
STAT3 controls myeloid progenitor growth during emergency granulopoiesis
Zhang, H., Nguyen-Jackson, H., Panopoulos, A. D., Li, H. S., Murray, P. J., & Watowich, S. S. (2010) · Blood · doi:10.1182/blood-2009-12-259630 · Cited by 232
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Shipitsin, M., & Polyak, K. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.14 · Cited by 231
“A stem cell biomarker will need to support the principle that the fate of the stem cell population determines response to treatment or outcomes from cancer and be reproducible and measurable in patient samples; a tall order considering the relatively few general biomarkers that have been successfully integrated into c…”
BackgroundDifferentiation and heterogeneity in the mononuclear phagocyte system
Hume, D. A. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.36 · Cited by 221
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Bayraktar, R., & Van Roosbroeck, K. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9724-7 · Cited by 216
“In addition, it was determined that the protein levels of SHIP1, a negative regulator of the PI3K pathway [18], and CCAAT enhancer-binding proteinβ (C/EBPβ), a lineage-specific transcription factor in the hematopoietic system [73], were dramatically downmodulated in the miR-155 transgenic pre-B lymphocytes, and that b…”
BackgroundSchürch, C. M., Riether, C., & Ochsenbein, A. F. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.002 · Cited by 214
Bertrand, J. Y., Kim, A. D., Teng, S., & Traver, D. (2008) · Development · doi:10.1242/dev.015297 · Cited by 214
“1 (spi1 – Zebrafish Information Network), transcription factors that act as master regulators of erythroid and myeloid fate commitment, respectively, in hematopoietic progenitor cells (Tenen et al., 1997; Miyamoto et al., 2002; Rosenbauer and Tenen, 2007).”
BackgroundResultChoi, K.-D., Vodyanik, M. A., & Slukvin, I. I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38591 · Cited by 212
Gfi1 and Gfi1b: key regulators of hematopoiesis
van der Meer, L. T., Jansen, J. H., & van der Reijden, B. A. (2010) · Leukemia · doi:10.1038/leu.2010.195 · Cited by 211
“The control of proliferation, differentiation and survival of blood cells by Gfi1 and Gfi1b shows striking functional similarities to a set of other hematopoietic transcription factors”
BackgroundBarozzi, I., Simonatto, M., Bonifacio, S., Yang, L., Rohs, R., Ghisletti, S., & Natoli, G. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.006 · Cited by 209
“We used primary mouse macrophages in which the ETS family TF Pu.1, the master regulator of the myeloid lineage (Nerlov and Graf, 1998; Rosenbauer and Tenen, 2007; Scott et al., 1994), binds virtually the entire repertoire of H3K4me1-positive regions and a large fraction of transcription start sites…”
Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer
Garcia-Alonso, L., Iorio, F., Matchan, A., Fonseca, N., Jaaks, P., Peat, G., Pignatelli, M., Falcone, F., Benes, C. H., Dunham, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1679 · Cited by 202
Pabst, T., Eyholzer, M., Haefliger, S., Schardt, J., & Mueller, B. U. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5563 · Cited by 201
Wouters, B. J., Jordà, M. A., Keeshan, K., Louwers, I., Erpelinck-Verschueren, C. A. J., Tielemans, D., Langerak, A. W., He, Y., Yashiro-Ohtani, Y., Zhang, P., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073486 · Cited by 199
Self-citationRiether, C., Schürch, C. M., Bührer, E. D., Hinterbrandner, M., Huguenin, A.-L., Hoepner, S., Zlobec, I., Pabst, T., Radpour, R., & Ochsenbein, A. F. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20152008 · Cited by 191
“In addition, the expression of the differentiation-inducing genes RUNX1, SPI1 (PU.1), CEBPα, CEBPβ, and ID1 (Rosenbauer and Tenen, 2007) was significantly increased in AML stem/progenitor cells cultured overnight in the presence of blocking αCD70 compared with control mAb (Fig.”
BackgroundInfluentialThe BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
Friedenson, B. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-152 · Cited by 188
“These theories are differentiation-maturation mutations cooperating with proliferation/survival mutations, lineageaddiction or -dependency models, and the existence of "cancer stem cells" arising from an ordered sequence of phenotypically distinct stem-cell and intermediate-precursor populations [62-64].”
BackgroundPU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
“PU.1 has to date been mainly implicated in the regulation of hematopoiesis where PU.1 is indispensable for normal myeloid and lymphoid development 14,15 and determines the fate of respective progenitors 45–48 .”
Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage
Huber, R., Pietsch, D., Panterodt, T., & Brand, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.007 · Cited by 187
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Xue, C., Chu, Q., Zheng, Q., Jiang, S., Bao, Z., Su, Y., Lu, J., & Li, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01003-0 · Cited by 183
“A novel SPI1-METTL14-MYB/MYC signaling axis plays an important role in myelopoiesis and leukemogenesis.321 In addition, Su et al.308 investigated the functional role of R-2-hydroxyglutaric acid (R-2HG), an oncogenic metabolite, in AML.”
BackgroundInfluentialSubtype-specific regulatory network rewiring in acute myeloid leukemia
Assi, S. A., Imperato, M. R., Coleman, D. J. L., Pickin, A., Potluri, S., Ptasinska, A., Chin, P. S., Blair, H., Cauchy, P., James, S. R., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0270-1 · Cited by 179
Dawson, M. A., Gudgin, E. J., Horton, S. J., Giotopoulos, G., Meduri, E., Robson, S., Cannizzaro, E., Osaki, H., Wiese, M., Putwain, S., et al. (2014) · Leukemia · doi:10.1038/leu.2013.338 · Cited by 175
The role of the GATA2 transcription factor in normal and malignant hematopoiesis
Vicente, C., Conchillo, A., García-Sánchez, M. A., & Odero, M. D. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.007 · Cited by 175
“ell-known examples of deregulated transcription factors re RUNX1/AML1 and C/EBPA in acute myeloid leukemia AML), SCL in T-cell acute lymphoblastic leukemia (TLL), and GATA1 in Down syndrome-acute megakaryocytic eukemia [2].”
BackgroundSu, R., Lin, H.-S., Zhang, X.-H., Yin, X.-L., Ning, H.-M., Liu, B., Zhai, P.-F., Gong, J.-N., Shen, C., Song, L., et al. (2015) · Oncogene · doi:10.1038/onc.2014.274 · Cited by 173
Yoneda, A., Lendorf, M. E., Couchman, J. R., & Multhaupt, H. A. B. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411428469 · Cited by 164
Differential Requirement for irf8 in Formation of Embryonic and Adult Macrophages in Zebrafish
Shiau, C. E., Kaufman, Z., Meireles, A. M., & Talbot, W. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117513 · Cited by 163
Sima, C., & Glogauer, M. (2013) · Periodontology 2000 · doi:10.1111/prd.12032 · Cited by 163
Irf8 regulates macrophage versus neutrophil fate during zebrafish primitive myelopoiesis
Li, L., Jin, H., Xu, J., Shi, Y., & Wen, Z. (2011) · Blood · doi:10.1182/blood-2010-06-290700 · Cited by 163
Wang, K., Wang, P., Shi, J., Zhu, X., He, M., Jia, X., Yang, X., Qiu, F., Jin, W., Qian, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.045 · Cited by 162
Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma
Grez, M., Reichenbach, J., Schwäble, J., Seger, R., Dinauer, M. C., & Thrasher, A. J. (2011) · Molecular Therapy · doi:10.1038/mt.2010.232 · Cited by 162
LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia
Tarumoto, Y., Lu, B., Somerville, T. D. D., Huang, Y.-H., Milazzo, J. P., Wu, X. S., Klingbeil, O., El Demerdash, O., Shi, J., & Vakoc, C. R. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.011 · Cited by 157
“…M anuscript A uthor M anuscript A uthor M anuscript Introduction Diverse genetic mutations that promote the hematopoietic malignancy acute myeloid leukemia (AML) are known to deregulate the expression of a common set of lineagespecifying transcription factors (TFs) (Rosenbauer and Tenen, 2007).”
BackgroundLee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 158
“Classically, macrophages are defined in flow cytometry analyses as CD11b? and F4/80?, while DCs are defined as CD11c?.”
InfluentialPabst, T., Eyholzer, M., Fos, J., & Mueller, B. U. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604977 · Cited by 163
“…www.bjcancer.com Published online 10 March 2009 & 2009 Cancer Research UK Keywords: prognosis; AML; mutations; CEBPA; risk assessment One of the crucial transcription factors for myeloid cell development is the CCAAT/enhancer binding protein alpha (CEBPA) (Rosenbauer and Tenen, 2007).”
BackgroundMicroRNA function in myeloid biology
O'Connell, R. M., Zhao, J. L., & Rao, D. S. (2011) · Blood · doi:10.1182/blood-2011-03-291971 · Cited by 157
Kurotaki, D., Yamamoto, M., Nishiyama, A., Uno, K., Ban, T., Ichino, M., Sasaki, H., Matsunaga, S., Yoshinari, M., Ryo, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5978 · Cited by 176
Hagemeyer, N., Kierdorf, K., Frenzel, K., Xue, J., Ringelhan, M., Abdullah, Z., Godin, I., Wieghofer, P., Jordão, M. J. C., Ulas, T., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201693801 · Cited by 155
“There are several transcription factors proven to be important for myeloid cell development including Pu.1, which affects multiple lineages of the hematopoiesis in an early stage including the development of M Φ (Rosenbauer & Tenen, 2007).”
InfluentialSelf-citationMYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia
Vargova, K., Curik, N., Burda, P., Basova, P., Kulvait, V., Pospisil, V., Savvulidi, F., Kokavec, J., Necas, E., Berkova, A., et al. (2011) · Blood · doi:10.1182/blood-2010-05-285064 · Cited by 144
“It has been recently demonstrated that miR-155 levels associate with (1) the increased ZAP70 expression in B-CLL,49 (2) a short duration to the onset of therapy,12 and (3) activated B-cell like phenotype of diffuse large B-cell lymphoma marking unfavorable prognosis.”
BackgroundDifferential expression of specific microRNA and their targets in acute myeloid leukemia
Cammarata, G., Augugliaro, L., Salemi, D., Agueli, C., Rosa, M. L., Dagnino, L., Civiletto, G., Messana, F., Marfia, A., Bica, M. G., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21667 · Cited by 153
“1 and CCAAT/enhancer binding proteins (in particular, C/EBP-alfa, C/EBP-beta, and C/EBP-epsilon) are considered key factors [53], all of them play an important role in the differentiation of myelopoiesis by regulating the expression of a number of myeloid target genes and loss or diminution of their activity may be ca…”
BackgroundHuman and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?
Reynolds, G., & Haniffa, M. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00330 · Cited by 153
Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells
Leddin, M., Perrod, C., Hoogenkamp, M., Ghani, S., Assi, S., Heinz, S., Wilson, N. K., Follows, G., Schönheit, J., Vockentanz, L., et al. (2011) · Blood · doi:10.1182/blood-2010-08-302976 · Cited by 131
“Auto-regulation is a common mechanism to adjust the expression of many transcription factors during cellular differentiation.(45;46;47) PU.”
BackgroundSelf-citationPlasma cells are obligate effectors of enhanced myelopoiesis in aging bone marrow
Pioli, P. D., Casero, D., Montecino-Rodriguez, E., Morrison, S. L., & Dorshkind, K. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.006 · Cited by 131
“These included key myeloid transcription factors such as Junb (Rosenbauer and Tenen, 2007) and Stat3 (Panopoulos et al.”
BackgroundInfluentialMacrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 127
A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages
Mancino, A., Termanini, A., Barozzi, I., Ghisletti, S., Ostuni, R., Prosperini, E., Ozato, K., & Natoli, G. (2015) · Genes & Development · doi:10.1101/gad.257592.114 · Cited by 125
“The ETS family TF PU.1 has a central role at all stages of myeloid development, starting from the transition from HSCs to common myeloid progenitors (CMPs) (Rosenbauer and Tenen 2007).”
BackgroundInfluentialPulikkan, J. A., Peramangalam, P. S., Dengler, V., Ho, P. A., Preudhomme, C., Meshinchi, S., Christopeit, M., Nibourel, O., Müller-Tidow, C., Bohlander, S. K., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281600 · Cited by 126
“7,8 C/EBP induces myeloid differentiation via 2 major steps: (1) up-regulation of myeloid-specific genes necessary for granulocytic maturation and (2) inhibition of myeloid cell proliferation.”
BackgroundMethodSelf-citationMicroglia: unique and common features with other tissue macrophages
Prinz, M., Tay, T. L., Wolf, Y., & Jung, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1267-1 · Cited by 126
“1 is exclusively expressed in the hematopoietic cell lineage and required for normal myeloid cell development among members of the ets family of transcription factors [110].”
BackgroundResearch Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing
Gu, L., Yan, W., Liu, L., Wang, S., Zhang, X., & Lyu, M. (2018) · Pharmaceuticals · doi:10.3390/ph11020035 · Cited by 126
“The TF regulates the velocity of transcription of genetic information from DNA to mRNA [72] and may influence multiple transcription-associated cellular processes including cell development, differentiation, and growth [73].”
BackgroundRUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
Kuvardina, O. N., Herglotz, J., Kolodziej, S., Kohrs, N., Herkt, S., Wojcik, B., Oellerich, T., Corso, J., Behrens, K., Kumar, A., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610519 · Cited by 123
“In themyeloid lineage, a limited number of transcription factors orchestrate myeloid differentiation.(60) However, it remains controversial whether transcription factors execute an extrinsic stimulus or independently contribute to lineage choice in vivo.”
BackgroundLiongue, C., Hall, C. J., O’Connell, B. A., Crosier, P. S., & Ward, A. C. (2009) · Blood · doi:10.1182/blood-2008-07-171967 · Cited by 135
Zhang, Y., Hu, J., & Zhang, C. (2012) · Analytical Chemistry · doi:10.1021/ac3024087 · Cited by 123
Tipping, A. J., Pina, C., Castor, A., Hong, D., Rodrigues, N. P., Lazzari, L., May, G. E., Jacobsen, S. E. W., & Enver, T. (2009) · Blood · doi:10.1182/blood-2008-06-161117 · Cited by 116
ADAR1 is required for hematopoietic progenitor cell survival via RNA editing
XuFeng, R., Boyer, M. J., Shen, H., Li, Y., Yu, H. M., Gao, Y., Yang, Q., Wang, Q., & Cheng, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903324106 · Cited by 133
Evidence for additive and synergistic action of mammalian enhancers during cell fate determination
Choi, J., Lysakovskaia, K., Stik, G., Demel, C., Söding, J., Tian, T. V., Graf, T., & Cramer, P. (2021) · eLife · doi:10.7554/elife.65381 · Cited by 117
Lin, M.-E., Chen, T. M., Wallingford, M. C., Nguyen, N. B., Yamada, S., Sawangmake, C., Zhang, J., Speer, M. Y., & Giachelli, C. M. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw205 · Cited by 125
Chromatin conformation signatures of cellular differentiation
Fraser, J., Rousseau, M., Shenker, S., Ferraiuolo, M. A., Hayashizaki, Y., Blanchette, M., & Dostie, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-4-r37 · Cited by 116
“For example, improper cellular differentiation in adult tissues can lead to human diseases such as leukemia [1,2].”
Background
Metadata
- Authors
- Rosenbauer, F., & Tenen, D. G.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 105-117
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1980860344
- Cited by
- 606
- References
- 142
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 45 · 2016: 31 · 2015: 42 · 2014: 38 · 2013: 43 · 2012: 27
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Lymphoma Research Foundation
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- transcription factors, myeloid development, myeloid differentiation, myeloid leukemia, differentiation block, transcription factor dysregulation, cell fate regulation
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Transcription Factors, Mice, Knockout, Cell Lineage, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.